ARCHIVES

Concurrent Trastuzumab and Anthracyclines Not Necessary for High Pathological Response

This article is from The Cancer Letter archive.

Vol. 36 No. 11 | November 29, 2013

Download PDF Visit The Full Archive

Related Articles

Letter: Cancer Centers Need Ingenuity To Continue Clinical Research

October 27, 1995

Raub Briefs Councils On Women’s Health, Cost Containment

October 12, 1990

Guest Editorial: MD Anderson’s Judith Smith Questions NCI Short-Term Remedy For Carboplatin Dosing

October 15, 2010

EntreMed Begins Phase I/II Trial For Endostatin.

July 27, 2001

NCI Letter to HCFA Outlines Positions, Offers Glimpse of Tactics

September 27, 1996

ASCO: NCI Director Should Be A Clinician; NBCC Endorses Mary-Claire King

March 10, 1995